CATX
Perspective Therapeutics, Inc.Company Information
- Company Name
- Perspective Therapeutics, Inc.
- CIK
- CIK0000728387
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CATX: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CATX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-13
- Last sale
- 2026-09-04
- Shares purchased (TTM)
- 20,498
- Shares sold (TTM)
- 358,961
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 87,383,102
- Shares outstanding
- 120,651,000
- Ownership
- 72.43%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 4.33%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 48 | 54 | 31 | 27 | 29 | 44 | 62 | 226 | 252 | 142 | 9 | 18 | ||||||
| Short Term Investments | 188 | 217 | 114 | 147 | 163 | 167 | 165 | 41 | 41 | 39 | 0 | 0 | ||||||
| Notes Receivable Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | ||||||
| Assets Current | 242 | 275 | 148 | 179 | 196 | 216 | 231 | 270 | 294 | 188 | 17 | 22 | ||||||
| Inventory Net | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | 0 | 0 | 0 | 5 | 5 | - | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 1 | 1 | 1 | 1 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Inventory Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | - | - | - | 50 | ||||||
| Property Plant And Equipment Net | 108 | 92 | 77 | 64 | 63 | 61 | 57 | 44 | 15 | 14 | 6 | 7 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | 40 | 40 | 40 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | - | ||||||
| Goodwill | - | - | - | - | - | - | 0 | 24 | 24 | 24 | 24 | 27 | ||||||
| Other Assets Noncurrent | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Assets | 392 | 411 | 267 | 295 | 311 | 329 | 341 | 391 | 386 | 278 | 98 | 111 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 29 | 26 | 21 | 13 | 7 | 9 | 10 | 22 | 6 | 6 | 7 | 4 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 37 | 31 | 29 | 21 | 13 | 13 | 18 | 28 | 11 | 15 | 16 | 8 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Employee Related Liabilities Current | 6 | 4 | 7 | 7 | 5 | 3 | 5 | 4 | 2 | - | 4 | - | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Deferred Income Current | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | - | ||||||
| Accrued Vacation Current | - | - | - | - | - | - | - | - | - | - | 0 | 1 | ||||||
Liabilities Other Than Long Term Debt Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||||||
| Long Term Notes Payable | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Asset Retirement Obligations Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | 0 | 0 | 0 | 5 | 5 | - | ||||||
| Other Notes Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Deferred Income Noncurrent | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 0 | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Deferred Income Tax Liabilities Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | - | ||||||
| Other Liabilities Noncurrent | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Liabilities | 68 | 63 | 60 | 53 | 45 | 45 | 50 | 63 | 45 | 48 | 23 | 12 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital Common Stock | 712 | 709 | 542 | 539 | 537 | 534 | 522 | 520 | 517 | 394 | 228 | 226 | ||||||
| Stockholders Equity | 324 | 347 | 207 | 242 | 266 | 285 | 291 | 328 | 341 | 230 | 75 | 99 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | -0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -388 | -361 | -335 | -297 | -271 | -250 | -232 | -192 | -176 | -165 | -152 | -128 | ||||||
| Liabilities And Stockholders Equity | 392 | 411 | 267 | 295 | 311 | 329 | 341 | 391 | 386 | 278 | 98 | 111 | ||||||
| Allowance For Doubtful Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | ||||||
| Common Stock Shares Issued | 114 | 114 | 74 | 74 | 74 | 74 | 71 | 68 | 67 | 59 | 28 | 28 | ||||||
| Shares Outstanding | 114 | 114 | 74 | 74 | 74 | 74 | 71 | 68 | 67 | 59 | 28 | 28 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPerspective Therapeutics, Inc. (CATX) — SEC Financial Statements & Analysis
Perspective Therapeutics, Inc. (CATX) is a pharmaceutical preparations company, incorporated in DE. Perspective Therapeutics, Inc. trades on NYSE as: CATX. Perspective Therapeutics, Inc. (CATX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Perspective Therapeutics, Inc. carries a market cap of $411.42M, a P/E ratio of -3.23x, a P/B ratio of 1.27x, a P/S ratio of 348.08x, an enterprise value of $364.53M, and an EV/EBITDA multiple of -2.79x. On profitability, it posts a gross margin of 33.56%, an operating margin of -2841.07%, a net margin of -3421.01%, a Return on Equity (ROE) of -43.18%, a Return on Assets (ROA) of -36.22%, and a Return on Invested Capital (ROIC) of -52.17%. Per share, it reports EPS of $-1.05, diluted EPS of $-1.05, free cash flow per share of $-1.74, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 27.64% year-over-year, and EPS growth of -21.46% year-over-year. On the balance sheet, it maintains a current ratio of 6.61x, a quick ratio of 6.49x, working capital of $204.98M, a debt-to-equity ratio of 0.21x, a debt ratio of 0.17, an interest coverage ratio of -1661.05x, free cash flow of $-210.11M (TTM), and net debt of $-46.89M. Figures sourced from SEC EDGAR.
- Market Cap
- $411.42M
- P/E TTM
- -3.23x
- EPS TTM
- $-1.05
- P/B TTM
- 1.27x
- ROE TTM
- -43.18%
- ROA TTM
- -36.22%
- Debt To Equity
- 0.21x
- Free Cash Flow TTM
- $-210.11M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Perspective Therapeutics, Inc. in?
Perspective Therapeutics, Inc. (CATX) operates in the Pharmaceutical Preparations industry.
What exchange does CATX trade on?
Perspective Therapeutics, Inc. (CATX) trades on the NYSE.
Where is Perspective Therapeutics, Inc. incorporated?
Perspective Therapeutics, Inc. is incorporated in DE.
When was Perspective Therapeutics, Inc. (CATX)'s most recent SEC filing?
Perspective Therapeutics, Inc. (CATX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is CATX's market cap?
Perspective Therapeutics, Inc. (CATX) has a market capitalization of $411.42M as of 2026-06-30.
What is CATX's EPS (earnings per share)?
Perspective Therapeutics, Inc. (CATX)'s trailing twelve month EPS is $-1.05 as of 2026-06-30.
What is CATX's ROE (return on equity)?
Perspective Therapeutics, Inc. (CATX)'s trailing twelve month Return on Equity (ROE) is -43.18% as of 2026-06-30.
What is CATX's ROA (return on assets)?
Perspective Therapeutics, Inc. (CATX)'s trailing twelve month Return on Assets (ROA) is -36.22% as of 2026-06-30.
What is CATX's ROIC (return on invested capital)?
Perspective Therapeutics, Inc. (CATX)'s trailing twelve month Return on Invested Capital (ROIC) is -52.17% as of 2026-06-30.
What is CATX's EV/EBITDA?
Perspective Therapeutics, Inc. (CATX)'s trailing twelve month EV/EBITDA is -2.79x as of 2026-06-30.